PharmaShots | Incisive News in 3 Shots

Subscribe Now

ImmPACT Bio

$ImmPACT Bio’ IMPT-514 Receives the US FDA’s Fast Track Designation for Refractory Lupus Nephritis and Systemic Lupus Erythematosus$

ImmPACT Bio’ IMPT-514 Receives the US FDA’s Fast Track Designation for Refractory Lupus Nephritis and Systemic Lupus Erythematosus

October 12, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us